关注
Litty Johnson
Litty Johnson
Researcher, University of Salzburg
在 plus.ac.at 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nanotechnology-based vaccines for allergen-specific immunotherapy: Potentials and challenges of conventional and novel adjuvants under research
L Johnson, A Duschl, M Himly
Vaccines 8 (2), 237, 2020
382020
Mechanisms of particles in sensitization, effector function and therapy of allergic disease
IA Joubert, M Geppert, L Johnson, R Mills-Goodlet, S Michelini, ...
Frontiers in Immunology 11, 1334, 2020
232020
The impact of nanoparticles on innate immune activation by live bacteria
BJ Swartzwelter, AC Fux, L Johnson, E Swart, S Hofer, N Hofstätter, ...
International Journal of Molecular Sciences 21 (24), 9695, 2020
222020
Computational prediction and experimental analysis of the nanoparticle-protein corona: Showcasing an in vitro-in silico workflow providing FAIR data
I Hasenkopf, R Mills-Goodlet, L Johnson, I Rouse, M Geppert, A Duschl, ...
Nano Today 46, 101561, 2022
172022
Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations
S Hofer, N Hofstätter, B Punz, I Hasenkopf, L Johnson, M Himly
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 14 (6 …, 2022
142022
EVAnalyzer: High content imaging for rigorous characterisation of single extracellular vesicles using standard laboratory equipment and a new open‐source ImageJ/Fiji plugin
M Schürz, J Danmayr, M Jaritsch, E Klinglmayr, HM Benirschke, CT Matea, ...
Journal of Extracellular Vesicles 11 (12), 12282, 2022
112022
Mechanistic investigations into the encapsulation and release of small molecules and proteins from a supramolecular nucleoside gel in vitro and in vivo
MGF Angelerou, R Markus, V Paraskevopoulou, R Foralosso, P Clarke, ...
Journal of Controlled Release 317, 118-129, 2020
112020
Surface functionalization of silica nanoparticles: strategies to optimize the immune-activating profile of carrier platforms
B Punz, L Johnson, M Geppert, HH Dang, J Horejs-Hoeck, A Duschl, ...
Pharmaceutics 14 (5), 1103, 2022
92022
The nanotopography of SiO 2 particles impacts the selectivity and 3D fold of bound allergens
R Mills-Goodlet, L Johnson, IJ Hoppe, C Regl, M Geppert, M Schenck, ...
Nanoscale 13 (48), 20508-20520, 2021
82021
Mechanistic insights into silica nanoparticle–allergen interactions on antigen presenting cell function in the context of allergic reactions
L Johnson, L Aglas, B Punz, HH Dang, C Christ, L Pointner, M Wenger, ...
Nanoscale 15 (5), 2262-2275, 2023
52023
Structural alterations of antigens at the material interface: An early decision toolbox facilitating safe-by-design nanovaccine development
L Johnson, L Aglas, WT Soh, M Geppert, S Hofer, N Hofstätter, P Briza, ...
International Journal of Molecular Sciences 22 (19), 10895, 2021
52021
Low molecular weight nucleoside Gelators: a platform for protein aggregation inhibition
L Johnson, MG Faidra Angelerou, BT Surikutchi, S Allen, M Zelzer, ...
Molecular Pharmaceutics 16 (1), 462-467, 2018
52018
Humanized mediator release assay as a read-out for allergen potency
M Wenger, A Bethanis, L Johnson, L Aglas
JoVE (Journal of Visualized Experiments), e62702, 2021
42021
Alignment of protein corona prediction from physics-based models with experimental analysis: showcasing an in vitro-in silico workflow providing FAIR data
I Hasenkopf, RD Mills-Goodlet, L Johnson, M Geppert, I Rouse, ...
Nano Today, 2022
12022
Reducing the solubility of the major birch pollen allergen Bet v 1 by particle-loading mitigates Th2 responses
A Kraiem, E Pelamatti, S Grosse-Kathoefer, H Demir, U Vollmann, ...
Allergology International, 2024
2024
Instance maps as an organising concept for complex experimental workflows as demonstrated for (nano) material safety research
B Punz, M Brajnik, J Dokler, JD Amos, L Johnson, K Reilly, ...
Beilstein Archives 2024 (1), 26, 2024
2024
& nbsp; Mechanisms of Particles in Sensitization, Effector Function and Therapy of Allergic Disease (vol 11, 1334, 2020)
IA Joubert, M Geppert, L Johnson, R Mills-Goodlet, S Michelini, A Duschl, ...
FRONTIERS IN IMMUNOLOGY 13, 2022
2022
In vitro immuno-nanotoxicological methods that take pre-existing conditions into account
M Himly, L Johnson, R Mills-Goodlet, I Hasenkopf, S Hofer, N Hofstaetter, ...
Toxicology Letters 350, S20, 2021
2021
A toolbox for early-stage suitability assessment of (nano-) particulate systems in AIT vaccine development
L Johnson, L Aglas, WT Soh, M Geppert, S Hofer, N Hofstätter, P Briza, ...
15th World Immune Regulation Meeting 2021, 2021
2021
Studying the stages of immune activation/modulation by silica nanoparticle-allergen conjugates: applying the AOP concept to immunotherapy development
L Johnson, L Aglas, M Geppert, S Hofer, N Hofstätter, WT Soh, F Ferreira, ...
NanoSafe Digital Conference 2020, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20